ChinaAMC Fund reduces its holdings of 3SBIO (01530) by 1,594,500 shares, at a price of 30.55 Hong Kong dollars per share.
On November 12, Huatai Fund reduced its holdings of Sanesco Pharmaceutical (01530) by 1.5945 million shares, with a price of 30.55 Hong Kong dollars per share, for a total amount of approximately 487.12 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that, on November 12th, Invesco Fund reduced its holdings of 3SBIO (01530) by 1.5945 million shares, with a price of 30.55 Hong Kong dollars per share, totaling approximately 487.12 million Hong Kong dollars. After the reduction, the latest number of holdings is approximately 146 million shares, with a latest holding percentage of 5.99%.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
